Pfizer Wins Further Drug Approval, Wells Fargo Buys U.K. Real Estate Assets, and 3 More Hot Stocks

  • Like on Facebook
  • Share on Google+
  • Share on LinkedIn

Pfizer Inc. (NYSE:PFE): Pfizer’s Tofacitinib treatment for rheumatoid arthritis has won approval in Switzerland, joining Argentina, Kuwait, the United Arab Emirates, the U.S., Japan, and Russia to grant the drug approval. The drug can be used in patients who did not respond as well to other treatments. Tofacitinib is expected to be rolled out domestically this month, in conjunction with Takeda.

PFE

More Articles About:

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business